PRA opens South Korean office

- Last updated on GMT

Related tags: Contract research organization, South korea

US CRO PRA International has opened a new office in South Korea, further extending its presence in Asia.

PRA has provided clinical trial services in South Korea since 2005 through a series of partnership deals and collaborations with local contract research organisations (CRO).

However, according to regional senior director of clinical operations Edward Ian, PRA decided to establish its own office in response to "increasing customer expectations and project needs."

PRA went on to say that South Korea is widely regarded as the one of the top centres for clinical trials in the region behind India, China and Japan.

The firm also said that the South Korean government's formation of KoNECT, a national enterprise network for clinical trials, further demonstrates the country's committment to the sector.

Related news

Show more

Related products

show more

What do big pharma companies spend on R&D?

What do big pharma companies spend on R&D?

Zymewire | 15-Aug-2019 | Technical / White Paper

The free Big Pharma R&D Spend report examines the financial performance and research & development investments of the top 25 pharmaceutical companies...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 05-Nov-2018 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Related suppliers

Follow us

Products

View more

Webinars